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Abstract
AIM: To investigate the influence of Trichuris  muris  (T. 
muris ) infection in a mouse model of genetic suscepti-
bility to inflammatory bowel disease, Mdr1a-/-.
METHODS: Mdr1a-/- mice were housed under specific 
pathogen free conditions to slow the development of 
colitis and compared to congenic FVB controls. Mice 
were infected with approximately 200 embryonated ova 
from T.  muris  and assessed for worm burden and his-
tological and functional markers of gut inflammation on 
day 19 post infection.
RESULTS: Mdr1a-/- mice exhibited a marked increase 
in susceptibility to T.  muris  infection with a 10-fold in-
crease in colonic worm count by day 19 pi  compared 
to FVB controls. Prior to infection, Mdr1a-/- exhibited 
low-level mucosal inflammation with evidence of an en-
hanced Th1 environment. T. muris  infection accelerated 
the progression of colitis in Mdr1a-/- as evidenced by 
marked increases in several indicators including histo-
logical damage score, mucosal CD4+ T-cell and DC in-
filtration and dramatically increased production of pro-
inflammatory cytokines.
CONCLUSION: These data provide further evidence 
of the complex interaction between T. muris  and an in-
flammatory bowel disease (IBD)-susceptible host which 
may have relevance to the application of helminth 
therapy in the treatment of human IBD.
© 2014 Baishideng Publishing Group Co., Limited. All rights 
reserved.
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Core tip: This study investigates the interaction be-
tween the helminth parasite Trichuris muris  (T. muris ) 
and Mdr1a-/- mice, a genetic model of inflammatory 
bowel disease linked to deficiency of a key transporter 
protein in the gut barrier. The main findings are that (1) 
Mdr1a mice exhibit dramatically increased susceptibility 
to worm infection compared to congenic controls and 
(2) challenge with T. muris  induces severe pathological 
changes consistent with a marked exacerbation of coli-
tis in this model with preliminary evidence pointing to 
worm persistence as a driver of this effect. These find-
ings will be of interest in the emerging field of helminth 
therapy in inflammatory bowel disease (IBD) providing 
further evidence of the complexity of worm interaction 
with an IBD-susceptible host.
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INTRODUCTION
The outcome of  infection with the gastrointestinal nema-
tode worm Trichuris, which occurs in a range of  mam-
malian species, is genetically determined and involves 
subversion of  host Th1 and Th2 immune responses to 
allow the worm to survive and colonise the gut[1,2]. This 
has led to the suggestion that helminths may have the po-
tential to reduce dysregulated gut inflammation in human 
diseases such as Crohn’s disease[3]. Clinical trials using the 
pig worm Trichuris suis (T. muris) in patients with active 
Crohn’s disease or ulcerative colitis have reported a sig-
nificant improvement in disease symptoms in a majority 
of  patients receiving this treatment although the numbers 
of  subjects tested remains relatively small[4,5]. There is 
currently a paucity of  information on the mechanisms by 
which helminths regulate inflammation in man and, there-
fore, the possible impact of  genetic variability on suscep-
tibility and response to helminth challenge, including the 
potential for adverse effects remains uncertain[6]. Studies 
in a range of  murine models of  colitis have shown vari-
able responses to infection with helminth species such as 
H. polygyrus, H. diminuta and T. spiralis including ameliora-
tion and exacerbation of  disease[7]. To date, there is little 
information on the effects of  Trichuris species in murine 
colitis with a single study showing severe inflammation 
in IL-10-/- mice infected with T. muris[8], although the 
precise contribution of  the infection to the inflammation 
that develops spontaneously in this model was unclear.
The aim of  the present study was to explore the impact 
of  T. muris infection on the intestinal inflammation seen 
in the Mdr1a-/- mouse model of  inflammatory bowel 
disease (IBD). These mice develop spontaneous colitis 
as a result of  a primary defect in the gut epithelial barrier 
caused by the deletion of  the Mdr1a gene which encodes 
P-glycoprotein, a xenobiotic transporter located in the 
apical membrane of  epithelial cells[9,10]. Recent stud-
ies have shown similarities between the transcriptomic 
changes occurring during early development of  colitis in 
Mdr1a-/-[11] and those associated with T. muris infection 
in susceptible mouse strains[12] making this an interesting 
model in which to investigate interaction of  the parasite 
with an IBD-susceptible host.
MATERIALS AND METHODS
Animals
Mdr1a-/- mice (KO) and the congenic background 
strain FVB (WT) were obtained from Taconic Farms 
(Germantown, New York) and bred and maintained 
under specific pathogen free condition in the Biological 
Services Facility of  the University of  Manchester. Mice 
had been backcrossed for 7 generations onto the FVB 
background and were periodically genotyped by poly-
merase chain reaction. Mice were housed individually in 
isolator cages with access to filtered water and standard 
chow and routinely monitored for outward signs of  
bowel disease (diarrhea, weight loss and rectal bleeding). 
Mice used in these studies were between 5 and 13 wk of  
age on infection with T. muris. A total of  43 animals (21 
FVB and 22 Mdr1a-/-) were used in these studies. All 
animal studies conformed to current United Kingdom 
Home Office legislation.
Parasites
The maintenance of  T. muris and the method used for 
infection were as described by Wakelin[13]. Mice were 
infected with approximately 200 embryonated eggs by 
oral gavage at day 0. Worm burden was assessed at day 
19 post infection (pi) by counting the number of  worms 
present in the caecum and first 4 cm of  large intestine as 
described previously[14]. For a low dose, 20 egg infection, 
embryonated eggs were counted individually into Ep-
pendorfs and dispensed to mice at day 0. T. muris excre-
tory/secretory protein (T. muris E/S) was produced as 
previously described[13].
Isolation of mesenteric lymph nodes
Mesenteric lymph nodes (MLNs) were removed on day 
19 pi and placed in 10 mL complete RPMI-1640 (PAA) 
containing 10% foetal calf  serum (FCS) (PAA, gold- 
inactivated), 100 U/mL penicillin (Gibco), 100 µg/mL 
streptomycin (Gibco) and 1% L-glutamine (Gibco) on 
ice. MLNC were washed three times and resuspended 
at 5 × 106 cells/mL in RPMI 1640 medium (Gibco) 
containing 10% fetal calf  serum, antibiotics as above, 
2 mmol/L L-glutamine (Gibco). The final cell suspen-
sion (1 mL) was placed in duplicate wells of  a 48 well 
culture plate (Costar). Cell suspensions were stimulated 
with concanavalin A (ConA) 2.5 µg/mL or 50 µg/mL 4 
h T. muris E/S and incubated at 37 ℃ in 5% CO2 . Con 
A stimulated mesenteric lymph node cell culture was re-
covered after 24 h. Similarly, after 48 h the T. muris E/S 
stimulated cell culture was harvested and stored at -20 ℃ 
for cytokine analysis.
Measurement of parasite specific antibody
Parasite specific IgG1 and IgG2a levels in mouse serum 
was determined by ELISA as described previously[15]. 
Briefly, microplates were coated with adult T. muris excre-
tory/secretory (E/S) antigen at 5 µg/mL (50 µL/well) 
in carbonate buffer pH 9.6. After washing with 0.05% 
Tween 20 in phosphate buffered saline (PBS-T), plates 
were blocked with PBS-T containing 2% bovine serum 
albumin. Serial dilutions of  mouse serum from 1:20 to 
1:2560 in PBS-T were added and plates were incubated 
for 1 h at 37 ℃. After washing 50 µL/well of  biotinylat-
ed rat anti-IgG1 (Serotec Ltd, Oxford, United Kingdom) 
or rat anti-IgG2a (BD Pharmingen, Oxford, United 
Kingdom) were added followed by streptavidin conju-
gated peroxidase and TMB detection at 405 nm.
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Cytokine analysis
The cytokines interleukin (IL)-5, IL-12p40 and inter-
feron (IFN)-γ were quantified by an in-house sandwich 
ELISA using capture and detection antibodies from BD 
Pharmingen (Oxford, United Kingdom). Plates were 
washed with PBS-T and blocked with 10% fetal calf  
serum in phosphate buffered saline. Standard curves pre-
pared with recombinant murine cytokine standards were 
used to quantify cytokines in experimental samples with 
OD at 405 nm on a MRXII microplate reader. IL-13 
and tumor necrosis factor (TNF)-α were analysed using 
commercial ELISA kits obtained from R and D Systems 
(Abingdon, United Kingdom) according to the manufac-
turer’s instructions.
Colonic epithelial cell isolation
Whole mouse colon was isolated, split longitudinally 
and washed in RPMI 1640 medium (PAA Laboratories, 
Yeovil, United Kingdom) supplemented with 100 U/mL 
penicillin and 100 µg/mL streptomycin. Colon was cut 
into small pieces (approximately 5 mm) and incubated in 
10 mL Dulbecco’s modified Eagle medium (Invitrogen, 
Paisley, United Kingdom) containing 20% FCS (PAA 
Laboratories, Yeovil, United Kingdom), 100 U/mL peni-
cillin, 100 µg/mL streptomycin and 1 mg/mL Dispase 
(Sigma-Aldrich) with gentle rotation at 37 ℃ for 90 min. 
Epithelial cells were released by gentle aspiration with a 
pipette. Following brief  centrifugation (750 g; 5 min), the 
epithelial cell pellet was washed in RPMI 1640 medium 
and re-pelleted. One milliliter of  TRIzol reagent (Invit-
rogen, Paisley, United Kingdom) was added and RNA 
isolated according to the manufacturer’s instructions.
Gene expression analysis
Colonocyte RNA was reverse transcribed using a com-
mercial first-strand cDNA synthesis kit (Amersham Bio-
sciences, Little Chalfont, United Kingdom) using random 
hexamers. Relative quantification of  gene expression was 
performed using assays designed by ProbeFinder soft-
ware (www.universalprobelibrary.com); this gives gene-
specific primer pairs combined with the appropriate 
hydrolysis probes [5-fluorescein (FAM)-labeled; 3-dark 
quencher dye] from the Universal Probe Library (UPL; 
Roche Diagnostics, Lewes, United Kingdom). Assays 
were performed using a Lightcycler480 (Roche Diagnos-
tics) in a 20 µL volume with 200 nmol/L of  each primer, 
100 nmol/L of  the UPL probe and approximately 0.3 
µg of  cDNA. Gene expression was quantified relative to 
β-actin.
Histology
Colon from mdr1a-/- or FVB controls was assessed his-
tologically for evidence of  inflammation and tissue injury 
using a previously described grading system[11]. Three 
main grading criteria with 4 different subgrades of  sever-
ity (0-3) in each were applied. The resulting combined 
score (maximum 9) indicates disease severity with 0-nor-
mal, 1-3-mild changes, 3-6-moderate changes, 7-9-severe 
changes.
Immunohistochemistry
Samples of  large intestine near to the caecum were ob-
tained from naïve or T. muris infected (day 19) mdr1a-/- 
and FVB mice were snap-frozen and stored in liquid 
nitrogen until analysis. Cryostat frozen sections (6 µm) 
were fixed in 4% paraformaldehyde (for CD4+ staining) or 
acetone (for dendritic cells, DC). For CD4+, sections were 
incubated with 5 µg/mL biotinylated CD4 antibody (Clone 
H129.19; BD Pharmingen), followed by Vectastain ABC 
kit (Vector Laboratories, Peterborough, United Kingdom) 
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Figure 1  Mdr1a-/- (KO) mice show increased susceptibility to Trichuris 
muris infection compared to FVB controls (WT). Data shows large intestinal 
worm burden measured on day 19 following infection with approximately 200 
embryonated Trichuris muris eggs. Each data point represents a single mouse (n 
= 6 in each group); the horizontal bar denotes the mean for each group. bP < 0.01.
Bhardwaj EK et al . Trichuris muris  infection in Mdr1a-/- mice
40      80     160     320    640    1280  2560   5120
Dilution
2.0
1.5
1.0
0.5
0.0
-0.5
O
D
IgG1
Naïve: FVB
Naive Mdr1a-/-
Infected: FVB
Infected Mdr1a-/-
A
40     80     160     320    640    1280  2560   5120
Dilution
1.5
1.0
0.5
0.0
-0.5
O
D
IgG2aB
Figure 2  Parasite-specific IgG1 and IgG2a antibody responses in the 
serum of naïve and Trichuris muris infected FVB (WT) and mdr1a-/- (KO) 
mice. Serum was taken from mice at day 19 post infection. Data shows mean 
± SD for n = 5-7 animals in each group. OD: Optical density.
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with the nuclear stain 4′,6′-diamidino-2-phenylindole.
Statistical analysis
All data are presented as mean ± SD with n indicating the 
number of  mice used. Statistical comparisons were per-
formed by either t test or ANOVA with Dunnett’s post 
test for multiple comparisons using GraphPad Prism 3.02 
software.
and colour development with 3,3’-diaminobenzidine. Sec-
tions were counterstained with haematoxylin QS. For DC, 
sections were rehydrated in PBS and incubated with bioti-
nylated anti-CD11c (BD Biosciences) and anti-cytokeratin 
(Sigma-Aldrich). Following incubation with Vectastain 
ABC kit (Vector Laboratories, Peterborough, United 
Kingdom), slides were treated with tyramide amplification 
reagents (PerkinElmer) and washed and counterstained 
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Figure 3  Cytokine production by mesenteric lymph nodes from naïve and Trichuris muris infected FVB (WT) and mdr1a-/- (PGP-KO) mice. Levels of Th1 
[interferon (IFN)γ, A; interleukin (IL)-12p40, C] and Th2 (IL-13, D; IL-5, E) and the pro-inflammatory cytokine [tumor necrosis factor (TNF)α, B] were measured in 
mesenteric lymph nodes (MLN) following in vitro stimulation with Trichuris muris (T. muris) E/S antigen. MLN were isolated on day 19 post infection in T. muris infected 
groups. Data is shown as mean + SD for n = 5 animals in each group aP < 0.05; bP < 0.01.
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RESULTS
Mdr1a-/- mice exhibit enhanced susceptibility to T. muris 
infection
Following infection of  Mdr1a- mice or the congenic 
background strain FVB with approximately 200 embryo-
nated T. muris eggs on day 0, the worm burden in the large 
intestine was analysed in both groups on day 19 pi (Fig-
ure 1). Previous evidence suggests that resistant mouse 
strains generally expel T. muris by day 19 pi while suscep-
tible strains will retain worms in the large intestine[16]. The 
worm count in FVB control mice was relatively low (11 
± 7) consistent with this strain having a resistant pheno-
type. In marked contrast, mice lacking the Mdr1a gene 
showed a 10-fold higher worm count (134 ± 28, P < 0.01) 
indicative of  worm retention and a significantly increased 
susceptibility to T. muris infection (Figure 1). Infection 
with T. muris is associated with a strong anti-parasite an-
tibody response which is suggested as a useful indicator 
of  the Th1/Th2 balance and, therefore the resistance 
or susceptibility to parasite infection[17]. Figure 2 shows 
the parasite-specific IgG1 and IgG2a antibody response 
in the serum of  naïve and T. muris infected FVB control 
and mdr1a-/- mice on day 19 pi Sera from infected FVB 
and mdr1a-/- mice contained parasite-specific IgG1 at 
equivalent levels. However, consistent with the increased 
susceptibility to T. muris infection seen in Mdr1a-/-, lev-
els of  anti-Trichuris IgG2a were only increased in the 
Mdr1a-/- mouse.
The increased retention of  worms in Mdr1a-/- com-
pared to FVB control could be the result of  an enhanced 
Th1 environment. Production of  the Th1 cytokine, IFNγ 
by MLN from naïve animals was higher in Mdr1a-/- than 
FVB (562 ± 561 pg/mL vs 149 ± 108 pg/mL, n = 5; see 
Figure 3) but this did not reach statistical significance (P 
> 0.05). However, analysis of  colonocytes isolated from 
these mice showed significant up-regulation of  genes that 
are known to be IFNγ-dependent. Expression of  Indole-
amine 2, 3 dioxygenase (IDO), a tryptophan catabolizing 
enzyme linked to susceptibility to T. muris infection[18] 
and interferon gamma inducible protein-10, (IP-10; 
CXCL-10) were markedly higher (30- and 7-fold respec-
tively) in naïve Mdr1a-/- mice compared to FVB controls 
(Figure 4). These data provide evidence that Mdr1a-/- 
mice have a pre-existing Th1 environment prior to infec-
tion with T. muris.
T. muris infection increases the severity of colitis in 
Mdr1a-/- mice
We next investigated the impact of  T. muris infection on 
colitis development in Mdr1a-/- mice. T. muris infection 
in FVB mice produced no significant clinical or histologi-
cal evidence of  colitis (Figure 5); both naïve and infected 
animals had normal colonic mucosal morphology with 
the exception of  one mouse with a minor inflammatory 
infiltrate on day 19 post infection (Figure 5B). In con-
trast, there was a major difference in colitis indicators in 
age-matched Mdr1a-/-. Naïve Mdr1a-/- showed a mod-
est disease score (1.5) indicative of  an existing low-level 
mucosal inflammation and consistent with the spontane-
ous, age-dependent development of  colitis in this model 
(Figure 5C). However, infection of  Mdr1a-/- with T. 
muris, was associated with a dramatic increase in disease 
score (3.6) with the colon showing loss of  architecture, 
a severe mixed inflammatory infiltrate and evidence of  
crypt abscess (Figure 5D and E). The pro-inflammatory 
effect of  T. muris infection in Mdr1a-/- was also evident 
in the cytokine response of  MLN isolated at day 19 pi 
(Figure 3). Production of  the Th1 cytokine IFNγ in FVB 
controls was not significantly increased by T. muris infec-
tion (Figure 3A) consistent with the ability of  this mouse 
strain to expel T. muris. However, infection of  Mdr1a-/- 
mice led to a dramatic increase in IFNγ production with 
levels approximately 7 fold higher than naïve animals (P 
< 0.01). A second Th1-associated cytokine, IL-12p40 and 
the pro-inflammatory cytokine TNFα showed a similar 
pattern with marked increases in infected Mdr1a-/- but 
not infected FVB mice. (Figure 3B and C). A different 
pattern was observed for Th2 cytokines (Figure 3D and E). 
IL-13 and IL-5 were elevated in both FVB and Mdr1a-/- 
following T. muris infection (Figure 3D and E) and while 
the increase was somewhat greater in Mdr1a-/-, this was 
significant only for IL-5 (Mdr1a-/-: 124.3 ± 78.7 pg/mL 
vs FVB: 48.3 ± 29.7 pg/mL, P < 0.05). Taken together, 
these data shows that whilst both FVB and Mdr1a-/- 
mount a Th2 reponse pi a significantly heightened Th1/
pro-inflammatory response is only seen in the Mdra1-/- 
mouse. Consistent with the significantly greater histologi-
cal disease score seen in Figure 5, infected Mdr1a-/- mice 
exhibited a significantly greater intestinal CD4+ T cell in-
filtrate compared to both infected wild type mice and un-
infected Mdr1a-/- mice (Figure 6). Likewise dendritic cells 
appeared more numerous in the gut tissue from infected 
Mdr1a-/- mice compared to uninfected mice and infected 
wild type mice, indicative of  a more inflamed environ-
ment (Figure 7). One possibility to explain these findings 
is that the worsened pathology in infected Mdr1a-/- mice 
may simply be a reflection of  the inflammatory response 
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Figure 4  Expression of interferon γ-dependent genes IDO and CXCL-10 
in colonocytes from naïve Mdr1a-/- and FVB mice. mRNA expression was 
measured relative to β-actin in each case. Data is expressed as fold change 
in expression in Mdr1a-/- colonocytes relative to FVB controls and is shown as 
mean ± SD for n = 4 preparations for each group. aP < 0.05, bP < 0.01 vs FVB 
groups.
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associated with greater exposure to worms rather an in-
crease in severity of  the underlying colitis present in this 
model. To investigate this possibility, mdr1a-/- and FVB 
mice were infected with a low dose T. muris infection. Low 
level infections established from 20 eggs are not expelled 
from any mouse strain[19] thus ensuring more equivalent 
antigen exposure between mouse strains with different 
susceptibility to T. muris infection. In this situation, both 
FVB and Mdr1a-/- strains harboured worms (4 ± 3 and 
10 ± 3; n = 5 respectively) at day 19 post infection. This 
is in marked contrast to high dose infection where only 
Mdr1a-/- mice harboured worms at this time point (Figure 
1). Importantly, despite the similarity in worm burden, 
gut pathology in Mdr1a-/- was still significantly worse as 
evidenced by the high disease score (mean score: infected 
Mdr1a-/- 4.1; infected FVB 1.4) consistent with T. muris 
accelerating the disease process in these animals.
DISCUSSION
This study provides further evidence of  the complex 
interaction between T. muris and IBD which may have 
relevance to the proposed use of  helminth therapy in the 
treatment of  IBD. Mice with a genetic predisposition to 
IBD, mediated by deletion of  an epithelial transporter 
(p-glycoprotein) that forms a key part of  the gut barrier, 
were shown to have a markedly increased susceptibil-
ity to infection with T. muris compared to the congenic 
background strain that was resistant to infection. The 
most likely driver of  increased susceptibility to infection 
in Mdr1a-/- would seem to be an enhanced Th1 environ-
ment. A recent study by Collett et al[11] showed upregula-
tion in expression of  a range of  IFNγ-dependent genes 
in Mdr1a-/- colon including IDO, T-cell specific GTPase 
and MHC Class Ⅱ subtypes that precedes the develop-
Bhardwaj EK et al . Trichuris muris  infection in Mdr1a-/- mice
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Figure 5  Histological analysis of proximal colon from FVB (WT) and mdr1a-/- (PGP-KO) mice. A-E: H and E stained sections from proximal colon of WT-N (A), 
WT-INF (B), KO-N (C) and KO-INF (D-E). Tissues were isolated on day 19 post-infection in Trichuris muris (T. muris) infected mice; F: Histological disease scores for 
colon from naïve (WT-N; KO-N) and T. muris infected (WT-INF; KO-INF) mice based on the grading system described by Collett et al[11], 2008. Bar shows mean values 
for each group aP < 0.05, bP < 0.01, n = 5 for each group. 
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ment of  active colonic inflammation. This is consistent 
with the present observation that expression of  IDO and 
CXCL-10 is elevated in colonocytes from Mdr1a-/- mice 
exhibiting little or no gut pathology. Similar increases in 
expression of  IFNγ-dependent genes are found in T. 
muris-susceptible mouse strains[12] while neutralisation of  
IFNγ effectively reversed susceptibility to infection by 
promoting worm expulsion[20-22].
The Mdr1a-/- strain is characterised by spontaneous 
and relatively slow development of  colitis[9,11] and the ani-
mals used in the present study were at an early stage with 
evidence of  modest inflammatory changes. The finding 
that challenge with T. muris rapidly induced severe patho-
logical changes consistent with an advanced stage of  coli-
tis in these animals was somewhat unexpected in light of  
evidence that infection with different parasitic helminths 
can prevent or ameliorate colonic inflammation[23].
Nevertheless, while a majority of  studies report 
beneficial effects, there have been reports of  enhanced 
disease following helminth infection. Infection with Hy-
menolepis diminuta resulted in a significant exacerbation of  
oxalazone-induced colitis in mice[24,25] despite evidence 
that the parasite prevents DNBS-induced colitis[26]. 
Similarly, Heligmosomoides polygyrus bakeri enhances gut in-
flammation induced by enteric infection with Citrobacter 
rodentium[27] but has protective effects in a number of  
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Figure 6  CD4+ T-cell infiltration associated with Trichuris muris infection in the proximal colon of FVB (WT) and mdr1a-/- (PGP-KO) mice. A: Immunohisto-
chemical staining for CD4+ T cells in naïve (WT-N; KO-N) and Trichuris muris (T. muris) infected (WT-INF; KO-INF) WT and PGP-KO mice; B: Mean data (± SD) from 
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other colitis models[28,29]. Surprisingly, there is little infor-
mation on T. muris in mouse models despite the fact that 
the porcine strain of  this parasite (T. suis) has been used 
in the majority of  human trials of  helminth therapy[30]. 
Wilson et al[8] showed development of  a lethal colitis in 
IL-10-/- mice infected with T. muris although the extent 
to which the parasite enhanced the colitis that develops 
spontaneously in these mice is unclear. A recent study 
showing close transcriptional similarities between human 
colitis and the response to T. muris infection, including 
changes in gene expression that could exacerbate inflam-
mation, has urged caution in the therapeutic use of  hel-
minths[6]. The present study adds some support to this 
view suggesting interdependence between genetic predis-
position to colitis and susceptibility to T. muris infection, 
most likely linked to the prevailing immune environment 
that determines the degree to which worms persist and 
their overall impact on mucosal inflammation. This could 
at best compromise the efficacy of  worm therapy but, at 
worst, potentially result in exacerbation of  the disease as 
demonstrated here. For example, the prevailing immune 
profile will clearly depend on the type of  IBD present; 
Crohn’s disease is characteristically a Th1 driven, IFNγ-
dominated inflammation while ulcerative colitis is pri-
marily Th2-mediated with little evidence of  an increased 
IFNγ response[31]. 
Key questions remain regarding the precise mecha-
nism by which T. muris exacerbates colitis in Mdr1a-/-. 
These relate to whether the effects of  T. muris infection 
vary according to the stage of  the disease (e.g., early devel-
opment or established colitis) and whether the exacerba-
tion of  colitis depends on worm persistence, number or 
both. The involvement of  the IL-17/IL-23 pathway in the 
responses observed is also worthy of  further investigation 
given recent evidence of  its role in both IBD pathogen-
esis and host response to helminth infection[32,33].
The relevance of  these findings to the use of  worm 
therapy in the treatment of  IBD in man is difficult to 
determine at this stage. The pigworm T. suis may not be 
able to establish for any length of  time in the human 
colon due to species incompatibility and the relatively 
few clinical trials conducted so far have not reported 
significant safety issues[7,34]. However, the potential for 
pathological effects in man continues to be raised[35] and 
information on the level and persistence of  worms fol-
lowing human administration and whether this varies 
across individuals is necessary but not currently available. 
The present study in Mdr1a-/- is relevant in that it shows 
that a predisposition to T. muris infection is associated 
with increased inflammation rather than amelioration. In 
this respect, the preliminary observation that low dose 
challenge with T. muris, which produces a persistent in-
fection but with low worm burden, produced a similar 
enhancement of  colitis to that seen with high dose in 
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Figure 7  Dendritic cell infiltration associated with Trichuris muris infection in the proximal colon of FVB (WT) and mdr1a-/- (PGP-KO) mice. Fluorescence 
staining (pink) for dendritic cells in frozen sections of proximal colon from naïve (WT-N; KO-N) and Trichuris muris (T. muris) infected (WT-INF; KO-INF) mice. Tissues 
were removed on day 19 post infection in T. muris infected mice. Original magnification × 20. Images are representative of tissues from 5 mice in each group.
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Mdr1a is intriguing. Further studies are clearly required 
but this could indicate that persistence of  worms rather 
than worm burden per se may be a key factor in determin-
ing whether effects on host inflammation are beneficial 
or detrimental.
In conclusion, these data, taken together with similar 
studies in man and other animal model of  IBD support 
the view that the impact of  helminths on IBD in a given 
situation may be difficult to predict because the balance 
between disease amelioration and exacerbation will de-
pend on a range of  factors including species compatibil-
ity, the prevailing immune environment and host genetic 
susceptibility.
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Trichuris infection than congenic controls resulting in higher numbers of worms 
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